April 25, 2023

Genovis Annual Report 2022 published

Regulatory
Genovis 2022 Annual Report is now available in Swedish and English at our website.

To read or download the annual report in Swedish, go to:

Årsredovisning 2022

To read or download the annual report in English, go to:

Annual Report 2022

For more information, please contact: Fredrik Olsson, CEO, Genovis AB Tel: +46 (0)70-276 46 56 fredrik.olsson@genovis.com

Genovis’ business concept is to apply its knowledge and customer driven innovation to design and provide tools for the development of the drugs of the future. Today Genovis sells several enzyme products known as SmartEnzymes™ all over the world in innovative product formats that facilitate development and quality control of biological drugs.

The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (US). Genovis shares are listed on Nasdaq First North Growth Market and Erik Penser Bank is the Company’s Certified Adviser, certifiedadviser@penser.se, tel: +46 (0)8-463 83 00.

Published reports can be downloaded from the Genovis website: https://investor.genovis.com/en/financial-reports/

Press Release _annual report_2022
Genovis_AR_2022_En
  • Svenska